Michael Müller

1.5k total citations
39 papers, 1.1k citations indexed

About

Michael Müller is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Michael Müller has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Michael Müller's work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Long-Term Effects of COVID-19 (5 papers). Michael Müller is often cited by papers focused on COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Long-Term Effects of COVID-19 (5 papers). Michael Müller collaborates with scholars based in Germany, Australia and United States. Michael Müller's co-authors include Tania C. Sorrell, David G. Le Couteur, Sarah N. Hilmer, Robert Hardy, J. Faoagali, Narelle George, Enrico Rukzio, Victoria C. Cogger, Lesley C. Wright and Rosemary T. Santangelo and has published in prestigious journals such as Free Radical Biology and Medicine, Annals of the New York Academy of Sciences and Journal of Nutrition.

In The Last Decade

Michael Müller

38 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Müller Germany 21 282 275 185 146 106 39 1.1k
Abdi Ghaffari Canada 21 206 0.7× 538 2.0× 159 0.9× 162 1.1× 88 0.8× 36 1.7k
Congcong Liu China 17 144 0.5× 292 1.1× 81 0.4× 87 0.6× 99 0.9× 87 1.2k
Junchen Li China 15 180 0.6× 267 1.0× 193 1.0× 73 0.5× 98 0.9× 56 831
Wenjing Chen China 18 129 0.5× 323 1.2× 140 0.8× 63 0.4× 49 0.5× 69 1.1k
Rongrong Wang China 20 143 0.5× 445 1.6× 157 0.8× 131 0.9× 86 0.8× 95 1.5k
Ali Ganji Iran 17 210 0.7× 252 0.9× 57 0.3× 63 0.4× 69 0.7× 64 1.1k
Fei Zhong China 20 129 0.5× 396 1.4× 189 1.0× 120 0.8× 137 1.3× 59 1.2k
Fei Lei China 27 87 0.3× 339 1.2× 192 1.0× 134 0.9× 184 1.7× 125 1.8k
Wenwen Zheng China 22 299 1.1× 556 2.0× 191 1.0× 174 1.2× 83 0.8× 93 1.7k
Yiming Wang China 17 102 0.4× 307 1.1× 116 0.6× 227 1.6× 199 1.9× 69 1.1k

Countries citing papers authored by Michael Müller

Since Specialization
Citations

This map shows the geographic impact of Michael Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Müller more than expected).

Fields of papers citing papers by Michael Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Müller. The network helps show where Michael Müller may publish in the future.

Co-authorship network of co-authors of Michael Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Müller. A scholar is included among the top collaborators of Michael Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Müller. Michael Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller‐Hilke, Brigitte, et al.. (2022). Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. Vaccines. 10(2). 322–322. 10 indexed citations
2.
Bloch, Wilhelm, Florian Javelle, Karsten Krüger, et al.. (2022). A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – indications for their potential involvement in the development of Long COVID?. Frontiers in Immunology. 13. 1070994–1070994. 24 indexed citations
3.
4.
Müller, Michael, et al.. (2022). Prolonged treadmill training is not able to prevent ovariectomy-induced bone loss. Frontiers in Physiology. 13. 1078857–1078857.
5.
Müller, Michael, et al.. (2022). Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production. BMC Medicine. 20(1). 29–29. 21 indexed citations
6.
Trinkmann, Frederik, Michael Müller, Nicolas Kahn, et al.. (2021). Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. European Respiratory Journal. 57(2). 2003002–2003002. 27 indexed citations
7.
Lang‐Meli, Julia, Jonas Fuchs, Hsi-en Ho, et al.. (2021). Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency. Journal of Clinical Immunology. 42(2). 253–265. 23 indexed citations
8.
Scheiblauer, Heinrich, Andreas Nitsche, Andreas Puyskens, et al.. (2021). Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Eurosurveillance. 26(44). 73 indexed citations
9.
Ristow, Oliver, Thomas Rückschloß, Michael Müller, et al.. (2018). Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. Journal of Cranio-Maxillofacial Surgery. 47(3). 491–499. 71 indexed citations
10.
Müller, Michael. (2011). Glutathione modulates the toxicity of, but is not a biologically relevant reductant for, the Pseudomonas aeruginosa redox toxin pyocyanin. Free Radical Biology and Medicine. 50(8). 971–977. 23 indexed citations
11.
Hilmer, Sarah N., Victoria C. Cogger, Michael Müller, & David G. Le Couteur. (2004). THE HEPATIC PHARMACOKINETICS OF DOXORUBICIN AND LIPOSOMAL DOXORUBICIN. Drug Metabolism and Disposition. 32(8). 794–799. 78 indexed citations
12.
George, Narelle, J. Faoagali, & Michael Müller. (1997). Silvazine™ (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns. 23(6). 493–495. 61 indexed citations
13.
Müller, Michael & Tania C. Sorrell. (1997). Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infection and Immunity. 65(6). 2483–2487. 9 indexed citations
14.
Müller, Michael & Tania C. Sorrell. (1995). Inhibition of the human platelet cyclooxygenase response by the naturally occurring phenazine derivative, 1-hydroxyphenazine. Prostaglandins. 50(5-6). 301–311. 41 indexed citations
15.
Schönfeld, J. v., et al.. (1993). Effect of cysteamine on insulin release and exocrine pancreatic secretionin vitro. Digestive Diseases and Sciences. 38(1). 28–32. 7 indexed citations
16.
Rünzi, Michael, Michael Müller, & H. Goebell. (1993). Endogenous somatostatin possibly controls pancreatic growth: Further evidence for feedback regulation. Regulatory Peptides. 47(1). 65–72. 5 indexed citations
17.
Layer, Peter, Manfred von der Ohe, Michael Müller, & C. Beglinger. (1991). Effects of Somatostatin on the Exocrine Pancreas. Scandinavian Journal of Gastroenterology. 26(2). 129–136. 22 indexed citations
18.
19.
Müller, Michael, et al.. (1988). Effects of Camostat, a Synthetic Protease Inhibitor, on Endocrine and Exocrine Pancreas of the Rat. Journal of Nutrition. 118(5). 645–650. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdi Ghaffari Breakdown of academic impact, for papers by Congcong Liu Breakdown of academic impact, for papers by Junchen Li Breakdown of academic impact, for papers by Wenjing Chen Breakdown of academic impact, for papers by Rongrong Wang Breakdown of academic impact, for papers by Ali Ganji Breakdown of academic impact, for papers by Fei Zhong Breakdown of academic impact, for papers by Fei Lei Breakdown of academic impact, for papers by Wenwen Zheng Breakdown of academic impact, for papers by Yiming Wang
Rankless by CCL
2026